403 related articles for article (PubMed ID: 30094164)
21. Evaluation of early-phase [
Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
[TBL] [Abstract][Full Text] [Related]
22. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
Fleisher AS; Chen K; Liu X; Roontiva A; Thiyyagura P; Ayutyanont N; Joshi AD; Clark CM; Mintun MA; Pontecorvo MJ; Doraiswamy PM; Johnson KA; Skovronsky DM; Reiman EM
Arch Neurol; 2011 Nov; 68(11):1404-11. PubMed ID: 21747008
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of
Lu J; Ju Z; Wang M; Sun X; Jia C; Li L; Bao W; Zhang H; Jiao F; Lin H; Yen TC; Cui R; Lan X; Zhao Q; Guan Y; Zuo C;
Eur Radiol; 2023 Jul; 33(7):4567-4579. PubMed ID: 37099173
[TBL] [Abstract][Full Text] [Related]
24. A computational pipeline for quantification of pulmonary infections in small animal models using serial PET-CT imaging.
Bagci U; Foster B; Miller-Jaster K; Luna B; Dey B; Bishai WR; Jonsson CB; Jain S; Mollura DJ
EJNMMI Res; 2013 Jul; 3(1):55. PubMed ID: 23879987
[TBL] [Abstract][Full Text] [Related]
25. A Semiautomated Method for Quantification of F 18 Florbetapir PET Images.
Joshi AD; Pontecorvo MJ; Lu M; Skovronsky DM; Mintun MA; Devous MD
J Nucl Med; 2015 Nov; 56(11):1736-41. PubMed ID: 26338898
[TBL] [Abstract][Full Text] [Related]
26. Validation of a spatial normalization method using a principal component derived adaptive template for [
Leuzy A; Heurling K; De Santi S; Bullich S; Hansson O; Lilja J
Am J Nucl Med Mol Imaging; 2020; 10(4):161-167. PubMed ID: 32929394
[TBL] [Abstract][Full Text] [Related]
27. Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone.
Andersen FL; Ladefoged CN; Beyer T; Keller SH; Hansen AE; Højgaard L; Kjær A; Law I; Holm S
Neuroimage; 2014 Jan; 84():206-16. PubMed ID: 23994317
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of MRI-guided attenuation correction techniques in time-of-flight brain PET/MRI.
Mehranian A; Arabi H; Zaidi H
Neuroimage; 2016 Apr; 130():123-133. PubMed ID: 26853602
[TBL] [Abstract][Full Text] [Related]
29. 18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification.
Alongi P; Sardina DS; Coppola R; Scalisi S; Puglisi V; Arnone A; Raimondo GD; Munerati E; Alaimo V; Midiri F; Russo G; Stefano A; Giugno R; Piccoli T; Midiri M; Grimaldi LME
J Neuroimaging; 2019 May; 29(3):383-393. PubMed ID: 30714241
[TBL] [Abstract][Full Text] [Related]
30. Atlas-guided generation of pseudo-CT images for MRI-only and hybrid PET-MRI-guided radiotherapy treatment planning.
Arabi H; Koutsouvelis N; Rouzaud M; Miralbell R; Zaidi H
Phys Med Biol; 2016 Sep; 61(17):6531-52. PubMed ID: 27524504
[TBL] [Abstract][Full Text] [Related]
31. Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Methodology for Research and Clinical Brain PET Applications.
Raman F; Grandhi S; Murchison CF; Kennedy RE; Landau S; Roberson ED; McConathy J;
J Alzheimers Dis; 2019; 70(4):1241-1257. PubMed ID: 31322571
[TBL] [Abstract][Full Text] [Related]
32. A new integrated dual time-point amyloid PET/MRI data analysis method.
Cecchin D; Barthel H; Poggiali D; Cagnin A; Tiepolt S; Zucchetta P; Turco P; Gallo P; Frigo AC; Sabri O; Bui F
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2060-2072. PubMed ID: 28674847
[TBL] [Abstract][Full Text] [Related]
33. Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation.
Lao PJ; Handen BL; Betthauser TJ; Cody KA; Cohen AD; Tudorascu DL; Stone CK; Price JC; Johnson SC; Klunk WE; Christian BT
Brain Imaging Behav; 2019 Apr; 13(2):345-353. PubMed ID: 29752653
[TBL] [Abstract][Full Text] [Related]
34. PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PET.
Gonzalez-Escamilla G; Lange C; Teipel S; Buchert R; Grothe MJ;
Neuroimage; 2017 Feb; 147():669-677. PubMed ID: 28039094
[TBL] [Abstract][Full Text] [Related]
35. Unified spatial normalization method of brain PET images using adaptive probabilistic brain atlas.
Zhang T; Nie B; Liu H; Shan B;
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3073-3085. PubMed ID: 35258689
[TBL] [Abstract][Full Text] [Related]
36. Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.
Joshi AD; Pontecorvo MJ; Clark CM; Carpenter AP; Jennings DL; Sadowsky CH; Adler LP; Kovnat KD; Seibyl JP; Arora A; Saha K; Burns JD; Lowrey MJ; Mintun MA; Skovronsky DM;
J Nucl Med; 2012 Mar; 53(3):378-84. PubMed ID: 22331215
[TBL] [Abstract][Full Text] [Related]
37. Optimal Reference Region to Measure Longitudinal Amyloid-β Change with
Bullich S; Villemagne VL; Catafau AM; Jovalekic A; Koglin N; Rowe CC; De Santi S
J Nucl Med; 2017 Aug; 58(8):1300-1306. PubMed ID: 28183994
[TBL] [Abstract][Full Text] [Related]
38. Generation of Structural MR Images from Amyloid PET: Application to MR-Less Quantification.
Choi H; Lee DS;
J Nucl Med; 2018 Jul; 59(7):1111-1117. PubMed ID: 29217736
[TBL] [Abstract][Full Text] [Related]
39. Thoracic aortic microcalcification activity in combined positron emission tomography and magnetic resonance imaging.
Nash J; Debono S; Whittington B; Kaczynski J; Clark T; Macnaught G; Semple S; van Beek EJR; Tavares A; Dey D; Williams MC; Slomka PJ; Newby DE; Dweck MR; Fletcher AJ
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2260-2270. PubMed ID: 38456972
[TBL] [Abstract][Full Text] [Related]
40. MR-less surface-based amyloid assessment based on 11C PiB PET.
Zhou L; Salvado O; Dore V; Bourgeat P; Raniga P; Macaulay SL; Ames D; Masters CL; Ellis KA; Villemagne VL; Rowe CC; Fripp J;
PLoS One; 2014; 9(1):e84777. PubMed ID: 24427295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
